Core Scientific, Inc. (NASDAQ:CORZ) is one of the 11 Best Performing IPOs in the Last 2 Years. Despite the decline in revenue and mixed analyst opinions, the company’s upside potential remains ...
We’ve trimmed our fair value estimate for narrow-moat-rated Fortive FTV to $87 per share from $89 to reflect our slightly more muted near-term revenue growth projections, partially offset by the time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback